IRC
MRNA icon

Investors Research Corp’s Moderna MRNA Stock Holding History

Investors Research Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,302
Closed -$91.2K – 816
2026
Q2 		$91.2K Hold
1,302
– – 0.02% 330
2026
Q1 		$66.1K Sell
1,302
-250
-16% -$11.7K 0.01% 370
2025
Q4 		$45.8K Sell
1,552
-925
-37% -$25.1K 0.01% 452
2025
Q3 		$64K Sell
2,477
-50
-2% -$1.4K 0.01% 420
2025
Q2 		$69.7K Hold
2,527
– – 0.01% 430
2025
Q1 		$71.6K Hold
2,527
– – 0.02% 415
2024
Q4 		$105K Hold
2,527
– – 0.02% 385
2024
Q3 		$169K Hold
2,527
– – 0.04% 327
2024
Q2 		$300K Hold
2,527
– – 0.07% 268
2024
Q1 		$269K Sell
2,527
-125
-5% -$12.6K 0.06% 282
2023
Q4 		$264K Hold
2,652
– – 0.06% 287
2023
Q3 		$274K Buy
2,652
+2,650
+132,500% +$296K 0.07% 278
2023
Q2 		$243 Hold
2
– – ﹤0.01% 1047
2023
Q1 		$307 Hold
2
– – ﹤0.01% 1076
2022
Q4 		$359 Hold
2
– – ﹤0.01% 1090
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1118
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1127
2022
Q1 		$0 Buy
+2
New +$337 ﹤0.01% 1071

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $187M AUM 21.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Investors Research Corp's MRNA Position: Q3 2026 in Review

Investors Research Corp sold out of Moderna (MRNA) in Q3 2026, closing a stake of 1,302 shares — an estimated $91.2K sold.

Investors Research Corp first reported a position in MRNA in Q1 2022 and held it in 18 quarters. The position peaked at $300K in Q2 2024. 31 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Investors Research Corp reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
  • Investors Research Corp sold 1,302 Moderna shares in Q3 2026, an estimated $91.2K.
  • Investors Research Corp first reported a position in Moderna in Q1 2022 and held it in 18 quarters.
  • Investors Research Corp's Moderna position peaked at $300K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.